Brian Nowosielski

The rise of weight-loss drugs has overtaken the US prescription drug market and significantly increased spending from 2022 to 2023.

In a testimony to the Senate Finance Committee, Andrew Witty discussed what led to the February Change Healthcare cyberattack and the organization’s response.

Researchers aimed to evaluate the efficacy of the OpenAI technology and offer guidance into its future implementation within health care services.

Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.

Researchers addressed the association of sleep quality and dietary intakes for patients with type 1 diabetes who use insulin pumps and continuous glucose monitoring.

As the H5N1 bird flu virus continues to spread across dairy cattle in the US, researchers and government health officials are ramping up testing to stop the spread.

Kelly Malkamaki, RPh, senior product pharmacy analyst at AssureCare, shared her experience and thoughts on medication adherence in the pharmacy.

US health officials are growing increasingly worried about rising syphilis cases and have begun creating framework to slow down the spread.

Nicolette Mathey, PharmD, founder of ATRIUM24 and DottiCRM, discussed software as a service within the pharmacy.

With expertise through antimicrobial stewardship experience, researchers believe antimicrobial stewardship pharmacists are vital in assisting diagnostic stewardship.

Researchers’ objective was to assess the short-term glycemic benefits of continuous glucose monitoring (CGM) systems compared with patients with type 1 diabetes (T1D) who self-monitor.

With more states allowing the use of recreational marijuana than ever before, researchers examined its effects among youth populations.

The approval for tovorafenib (Ojemda) was based on data from the phase 2 FIREFLY-1 trial, in which the therapy demonstrated an overall repose rate of 67%.

Collecting smell and taste scores from individuals with and without a history of COVID-19, researchers found significantly lower scores for smell in COVID-19-diagnosed individuals.

Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.

Researchers were unable to find a significant benefit for patients for the majority of cancer medications given accelerated FDA approval.

With the judge’s failure to approve a settlement class, a $13.5 million settlement against Eli Lilly was called off.

The DEA informed community pharmacists on e-prescribing fraud and measures necessary to detect it.

A string of thefts at local pharmacies has spurred the DEA to issue warnings and share tips for independent pharmacists to keep their stores secure.

Since a 2019 measles outbreak, the CDC has seen an increasing number of cases in the US.

The CDC addressed an HPAI A(H5N1) virus infection reported by a commercial dairy farmer in Texas.

Governor Glenn Youngkin vetoed bills HB570 and SB274 that would have allowed the state to establish its first Prescription Drug Affordability Board.

Researchers addressed pharmacists’ role in mitigating drug shortages.

With drug price negotiations for 10 drugs through the Inflation Reduction Act (IRA) set to take effect in 2026, researchers simulated the extent of Medicare savings.

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

It can be hard to look away from a once in a lifetime total eclipse, but it’s important to understand the risks that come with viewing.

In comparison with the traditional volume-based pharmacy model, the membership model decreases financial barriers while increasing customer-pharmacist relationships.

Researchers found various reasons for why individuals chose a specific pharmacy and how they purchase OTC medication.

Thanks to the Inflation Reduction Act, Medicare Part B coinsurance rates will lower if drug prices rise faster than the rate of inflation.

Researchers detailed the FDA’s recommendations on low-dose aspirin and pharmacists’ role in cardiovascular practice transformation programs.